Clinical Trial Update: Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update investigating intratracheal administration of umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Intratracheal Umbilical Cord-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: China Medical University Hospital | Conditions: Bronchopulmonary Dysplasia, Extremely Premature Infants | Phase 1 | Status: UNKNOWN